Business Description
AcuCort AB
ISIN : SE0009695927
Total Employee Number:
5Compare
Compare
Traded in other countries / regions
ACUC.SwedenNV5.Germany IPO Date
2017-04-24Description
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.92 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 12.04 | |||||
Beneish M-Score | -3.05 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 41.1 | |||||
3-Year EPS without NRI Growth Rate | 32.9 | |||||
3-Year FCF Growth Rate | 39 | |||||
3-Year Book Growth Rate | -34.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.89 | |||||
9-Day RSI | 56.62 | |||||
14-Day RSI | 52.59 | |||||
3-1 Month Momentum % | -9.17 | |||||
6-1 Month Momentum % | 7.74 | |||||
12-1 Month Momentum % | -13.38 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.31 | |||||
Quick Ratio | 4.31 | |||||
Cash Ratio | 3.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -71.5 | |||||
Shareholder Yield % | -4.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 1094.11 | |||||
Operating Margin % | -3940.8 | |||||
Net Margin % | -3902.65 | |||||
EBITDA Margin % | -2673.49 | |||||
FCF Margin % | -3375.7 | |||||
OCF Margin % | -2381.59 | |||||
ROE % | -39.1 | |||||
ROA % | -36.87 | |||||
ROIC % | -63.73 | |||||
3-Year ROIIC % | -174.91 | |||||
ROCE % | -38.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 212.66 | |||||
PB Ratio | 2.62 | |||||
Price-to-Tangible-Book | 7.98 | |||||
EV-to-EBIT | -4.87 | |||||
EV-to-EBITDA | -7.07 | |||||
EV-to-Revenue | 189.14 | |||||
EV-to-FCF | -5.62 | |||||
| Price-to-Net-Current-Asset-Value | 9.11 | |||||
| Price-to-Net-Cash | 9.11 | |||||
Earnings Yield (Greenblatt) % | -20.52 | |||||
FCF Yield % | -15.33 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AcuCort AB Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 0.679 | ||
| EPS (TTM) (kr) | -0.14 | ||
| Beta | 2.0626 | ||
| 3-Year Sharpe Ratio | 0.13 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 53.69 | ||
| 14-Day RSI | 52.59 | ||
| 14-Day ATR (kr) | 0.053183 | ||
| 20-Day SMA (kr) | 0.5983 | ||
| 12-1 Month Momentum % | -13.38 | ||
| 52-Week Range (kr) | 0.401 - 0.95 | ||
| Shares Outstanding (Mil) | 234.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AcuCort AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AcuCort AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 122 days | ||
| Second quarter earnings results for 2026 | 2026-08-12 | In 29 days | ||
| General meeting for 2025 | 2026-05-27 16:30 | 0.71 (+4.41%) | ||
| First quarter earnings results for 2026 | 2026-04-28 | 0.80 (+2.57%) | ||
| Annual report for 2025 | 2026-04-14 | 0.72 (+4.05%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-20 | 0.93 (-0.43%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 0.59 (-1.67%) | ||
| Second quarter earnings results for 2025 | 2025-08-19 | 0.62 (+1.96%) | ||
| General meeting for 2024 | 2025-05-12 16:30 | 0.79 (-1.63%) | ||
| First quarter earnings results for 2025 | 2025-05-08 | 0.72 (+2.28%) |
Show
Entries
AcuCort AB Frequently Asked Questions
What is AcuCort AB(XSAT:ACUC)'s stock price today?
The current price of XSAT:ACUC is kr0.64. The 52 week high of XSAT:ACUC is kr0.95 and 52 week low is kr0.40.
When is next earnings date of AcuCort AB(XSAT:ACUC)?
The next earnings date of AcuCort AB(XSAT:ACUC) is 2026-08-12.
Does AcuCort AB(XSAT:ACUC) pay dividends? If so, how much?
AcuCort AB(XSAT:ACUC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on AcuCort AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers